General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)

CompletedOBSERVATIONAL
Enrollment

409

Participants

Timeline

Start Date

February 28, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Cervical RipeningPregnancy
Interventions
OTHER

PROPESS Cohort

Non-intervention

Trial Locations (1)

565-0871

Osaka University Hospital (there may be other sites in this country), Osaka

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY